For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.

29th Sep 11

Phase II Trial in Subjects with Allergic Asthma Completes Enrolment

Pharmaxis today announced it has completed enrolment of all subjects into its Phase II clinical trial evaluating ASM8, a potential new treatment for patients with moderate to severe asthma.


Read full media release - pdf